Foley Hoag’s highly trained, respected, and experienced patent prosecution professionals can meet your legal needs at many levels. We believe that strategic counsel for developing and managing intellectual property is essential to your ability to succeed in an increasingly sophisticated and competitive marketplace. And our clients’ success is our ultimate goal.

Publications more

  • Intellectual Property Alert: New Low-Fee Search Option and Expedited Examination for US-based International Patent Applications [Read More]
  • Genes, Coding, and Bold Action [Read More]
  • Intellectual Property Alert: Federal Appeals Court Requires Insurers to Defend Patent Infringement Suit Under Standard Commercial Liability Policies [Read More]
  • Intellectual Property Alert: Ten Features of the New Patent Law Patent Applicants Should Know [Read More]
  • Intellectual Property Alert: Opportunity for Immediate Benefit from Patent Reform [Read More]

Client Successes more

  • Global Bio-Chem Technology Group Company Limited
    Our lawyers, in conjunction with Adduci, Mastriani & Schaumberg LLP and East Associates, represented Global Bio-Chem Technology Group Company Limited and its affiliates (GBT), the largest lysine producer in China and the largest vertically integrated corn-based biochemical manufacturer in Asia, which prevailed after an evidentiary hearing before the United States International Trade Commission (USITC) in a patent infringement investigation brought by Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto). In a ruling in July 2008, the Administrative Law Judge (ALJ) held that the claims of Ajinomoto’s two patents were invalid for failure to disclose the best mode of practicing the invention, thus finding no violation of Section 337 of the Tariff Act of 1930. The ALJ also ruled that both patents were unenforceable because Ajinomoto had committed inequitable conduct. [Read More]
  • Driving Biopharma Forward
    Our lawyers identified, on the eve of FDA approval of one of our client's biopharmaceuticals, a prior public use that would cause a court to invalidate the otherwise blocking patent claims. This enabled our client to negotiate a license under the patent on commercially reasonable terms. [Read More]